Breast cancer is the most common malignancy in women in the United States and is second only to lung cancer as a cause of cancer death. The overall management of breast cancer includes the treatment of local disease with surgery, radiation therapy, or both, and the treatment of systemic disease with cytotoxic chemotherapy, endocrine therapy, biologic therapy, or combinations of these. This article outlines the NCCN Guidelines specific to breast cancer that is locoregional (restricted to one region of the body), and discusses the management of clinical stage I, II, and IIIA (T3N1M0) tumors. For NCCN Guidelines on systemic adjuvant therapy after locoregional management of clinical stage I, II and IIIA (T3N1M0) and for management for other clinical stages of breast cancer, see the complete version of these guidelines at NCCN.org.

  • 1.

    SiegelRLMillerKDJemalA. Cancer statistics, 2016. CA Cancer J Clin2016;66:730.

  • 2.

    MohammadHForouzanfarKJFDelossantosAM. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet2011;6736:6135161352.

    • Search Google Scholar
    • Export Citation
  • 3.

    GailMHCostantinoJPBryantJ. Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. J Natl Cancer Inst1999;91:18291846.

    • Search Google Scholar
    • Export Citation
  • 4.

    DupontWDPageDL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med1985;312:146151.

  • 5.

    GiordanoSHBuzdarAUHortobagyiGN. Breast cancer in men. Ann Intern Med2002;137:678687.

  • 6.

    GiordanoSHValeroVBuzdarAUHortobagyiGN. Efficacy of anastrozole in male breast cancer. Am J Clin Oncol2002;25:235237.

  • 7.

    RibeiroGSwindellR. Adjuvant tamoxifen for male breast cancer (MBC). Br J Cancer1992;65:252254.

  • 8.

    de RondeWde JongFH. Aromatase inhibitors in men: effects and therapeutic options. Reprod Biol Endocrinol2011;9:93.

  • 9.

    EggemannHIgnatovASmithBJ. Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients. Breast Cancer Res Treat2013;137:465470.

    • Search Google Scholar
    • Export Citation
  • 10.

    LouieRJTonnesonJEGowartyM. Complete blood counts, liver function tests, and chest x-rays as routine screening in early-stage breast cancer: value added or just cost?Breast Cancer Res Treat2015;154:99103.

    • Search Google Scholar
    • Export Citation
  • 11.

    EssermanL. Integration of imaging in the management of breast cancer. J Clin Oncol2005;23:16011602.

  • 12.

    GundryKR. The application of breast MRI in staging and screening for breast cancer. Oncology (Williston Park)2005;19:159169.

  • 13.

    HoussamiNCiattoSMacaskillP. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol2008;26:32483258.

    • Search Google Scholar
    • Export Citation
  • 14.

    WeberJJBellinLSMilbournDE. Selective preoperative magnetic resonance imaging in women with breast cancer: no reduction in the reoperation rate. Arch Surg2012;147:834839.

    • Search Google Scholar
    • Export Citation
  • 15.

    FeigelsonHSJamesTASingleRM. Factors associated with the frequency of initial total mastectomy: results of a multi-institutional study. J Am Coll Surg2013;216:966975.

    • Search Google Scholar
    • Export Citation
  • 16.

    KatipamulaRDegnimACHoskinT. Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol2009;27:40824088.

    • Search Google Scholar
    • Export Citation
  • 17.

    SorberoMEDickAWBeckjordEBAhrendtG. Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy. Ann Surg Oncol2009;16:15971605.

    • Search Google Scholar
    • Export Citation
  • 18.

    MillerBTAbbottAMTuttleTM. The influence of preoperative MRI on breast cancer treatment. Ann Surg Oncol2012;19:536540.

  • 19.

    PetersNHvan EsserSvan den BoschMA. Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET—randomised controlled trial. Eur J Cancer2011;47:879886.

    • Search Google Scholar
    • Export Citation
  • 20.

    TurnbullLWBrownSROlivierC. Multicentre randomised controlled trial examining the cost-effectiveness of contrast-enhanced high field magnetic resonance imaging in women with primary breast cancer scheduled for wide local excision (COMICE). Health Technol Assess2010;14:1182.

    • Search Google Scholar
    • Export Citation
  • 21.

    FischerUZachariaeOBaumF. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol2004;14:17251731.

    • Search Google Scholar
    • Export Citation
  • 22.

    SolinLJOrelSGHwangWT. Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol2008;26:386391.

    • Search Google Scholar
    • Export Citation
  • 23.

    BleicherRJCioccaRMEglestonBL. Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg2009;209:180187; quiz 294–185.

    • Search Google Scholar
    • Export Citation
  • 24.

    TurnbullLBrownSHarveyI. Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet2010;375:563571.

    • Search Google Scholar
    • Export Citation
  • 25.

    WhiteJMorrowMMoughanJ. Compliance with breast-conservation standards for patients with early-stage breast carcinoma. Cancer2003;97:893904.

    • Search Google Scholar
    • Export Citation
  • 26.

    WilkinsonNWShahryarinejadAWinstonJS. Concordance with breast cancer pathology reporting practice guidelines. J Am Coll Surg2003;196:3843.

    • Search Google Scholar
    • Export Citation
  • 27.

    BaucomDHPorterLSKirbyJS. Psychosocial issues confronting young women with breast cancer. Breast Dis2005;23:103113.

  • 28.

    DunnJStegingaSK. Young women's experience of breast cancer: defining young and identifying concerns. Psychooncology2000;9:137146.

  • 29.

    GanzPAGreendaleGAPetersenL. Breast cancer in younger women: reproductive and late health effects of treatment. J Clin Oncol2003;21:41844193.

    • Search Google Scholar
    • Export Citation
  • 30.

    GormanJRBaileySPierceJPSuHI. How do you feel about fertility and parenthood? The voices of young female cancer survivors. J Cancer Surviv2012;6:200209.

    • Search Google Scholar
    • Export Citation
  • 31.

    Howard-AndersonJGanzPABowerJEStantonAL. Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review. J Natl Cancer Inst2012;104:386405.

    • Search Google Scholar
    • Export Citation
  • 32.

    KranickJASchaeferCRowellS. Is pregnancy after breast cancer safe?Breast J2010;16:404411.

  • 33.

    SukumvanichPCaseLDVan ZeeK. Incidence and time course of bleeding after long-term amenorrhea after breast cancer treatment: a prospective study. Cancer2010;116:31023111.

    • Search Google Scholar
    • Export Citation
  • 34.

    QuinnGPBlockRGClaymanML. If you did not document it, it did not happen: rates of documentation of discussion of infertility risk in adolescent and young adult oncology patients' medical records. J Oncol Pract2015;11:137144.

    • Search Google Scholar
    • Export Citation
  • 35.

    YeeSAbrolKMcDonaldM. Addressing oncofertility needs: views of female cancer patients in fertility preservation. J Psychosoc Oncol2012;30:331346.

    • Search Google Scholar
    • Export Citation
  • 36.

    YeomansonDJMorganSPaceyAA. Discussing fertility preservation at the time of cancer diagnosis: dissatisfaction of young females. Pediatr Blood Cancer2013;60:19962000.

    • Search Google Scholar
    • Export Citation
  • 37.

    LorenAWManguPBBeckLN. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol2013;31:25002510.

    • Search Google Scholar
    • Export Citation
  • 38.

    CruzMRPrestesJCGimenesDLFanelliMF. Fertility preservation in women with breast cancer undergoing adjuvant chemotherapy: a systematic review. Fertil Steril2010;94:138143.

    • Search Google Scholar
    • Export Citation
  • 39.

    DunnLFoxKR. Techniques for fertility preservation in patients with breast cancer. Curr Opin Obstet Gynecol2009;21:6873.

  • 40.

    OktemOOktayK. Fertility preservation for breast cancer patients. Semin Reprod Med2009;27:486492.

  • 41.

    RedigAJBranniganRStrykerSJ. Incorporating fertility preservation into the care of young oncology patients. Cancer2011;117:410.

  • 42.

    LeeSOzkavukcuSHeytensE. Value of early referral to fertility preservation in young women with breast cancer. J Clin Oncol2010;28:46834686.

    • Search Google Scholar
    • Export Citation
  • 43.

    PeateMMeiserBFriedlanderM. It's now or never: fertility-related knowledge, decision-making preferences, and treatment intentions in young women with breast cancer—an Australian fertility decision aid collaborative group study. J Clin Oncol2011;29:16701677.

    • Search Google Scholar
    • Export Citation
  • 44.

    BlumenfeldZEvronA. Preserving fertility when choosing chemotherapy regimens—the role of gonadotropin-releasing hormone agonists. Expert Opin Pharmacother2015;16:10091020.

    • Search Google Scholar
    • Export Citation
  • 45.

    Del MastroLLambertiniM. Temporary ovarian suppression with gonadotropin-releasing hormone agonist during chemotherapy for fertility preservation: toward the end of the debate?Oncologist2015;20:12331235.

    • Search Google Scholar
    • Export Citation
  • 46.

    LambertiniMPeccatoriFAMooreHCDel MastroL. Reply to the letter to the editor ‘Can ovarian suppression with gonadotropin releasing hormone analogs (GnRHa) preserve fertility in cancer patients?’ by Rodriguez-Wallberg et al[published online ahead of print December 8 2015]. Ann Oncolin press.

    • Search Google Scholar
    • Export Citation
  • 47.

    MooreHCUngerJMPhillipsKA. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. N Engl J Med2015;372:923932.

  • 48.

    MoffatRGuthU. Preserving fertility in patients undergoing treatment for breast cancer: current perspectives. Breast Cancer (Dove Med Press)2014;6:93101.

    • Search Google Scholar
    • Export Citation
  • 49.

    OktayKTuranVBedoschiG. Fertility preservation success subsequent to concurrent aromatase inhibitor treatment and ovarian stimulation in women with breast cancer. J Clin Oncol2015;33:24242429.

    • Search Google Scholar
    • Export Citation
  • 50.

    Baseline staging tests in primary breast cancer: Practice guideline report # 1-14: Members of the Breast Cancer Disease Site Group. Available at: http://www.cancercare.on.ca/common/pages/UserFile.aspx?serverId=6&path=/File%20Database/CCO%20Files/PEBC/pebc1-14f.pdfAccessed: February 12 2016.

    • Search Google Scholar
    • Export Citation
  • 51.

    RavaioliAPasiniGPolselliA. Staging of breast cancer: new recommended standard procedure. Breast Cancer Res Treat2002;72:5360.

  • 52.

    PuglisiFFolladorAMinisiniAM. Baseline staging tests after a new diagnosis of breast cancer: further evidence of their limited indications. Ann Oncol2005;16:263266.

    • Search Google Scholar
    • Export Citation
  • 53.

    BrothersJMKidwellKMBrownRKHenryNL. Incidental radiologic findings at breast cancer diagnosis and likelihood of disease recurrence. Breast Cancer Res Treat2016;155:395403.

    • Search Google Scholar
    • Export Citation
  • 54.

    KumarRChauhanAZhuangH. Clinicopathologic factors associated with false negative FDG-PET in primary breast cancer. Breast Cancer Res Treat2006;98:267274.

    • Search Google Scholar
    • Export Citation
  • 55.

    PodoloffDAAdvaniRHAllredC. NCCN Task Force Report: positron emission tomography (PET)/computed tomography (CT) scanning in cancer. J Natl Compr Canc Netw2007;5(Suppl 1):1271.

    • Search Google Scholar
    • Export Citation
  • 56.

    RosenELEubankWBMankoffDA. FDG PET, PET/CT, and breast cancer imaging. Radiographics2007;27(Suppl 1):S215229.

  • 57.

    WahlRLSiegelBAColemanREGatsonisCG. Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging breast cancer with PET Study Group. J Clin Oncol2004;22:277285.

    • Search Google Scholar
    • Export Citation
  • 58.

    ArriagadaRLeMGRochardFContessoG. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol1996;14:15581564.

    • Search Google Scholar
    • Export Citation
  • 59.

    ClarkeMCollinsRDarbyS. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet2005;366:20872106.

    • Search Google Scholar
    • Export Citation
  • 60.

    FisherBAndersonSBryantJ. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med2002;347:12331241.

    • Search Google Scholar
    • Export Citation
  • 61.

    VeronesiUCascinelliNMarianiL. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med2002;347:12271232.

    • Search Google Scholar
    • Export Citation
  • 62.

    Early Breast Cancer Trialists' Collaborative GDarbySMcGaleP. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet2011;378:17071716.

    • Search Google Scholar
    • Export Citation
  • 63.

    MoranMSSchnittSJGiulianoAE. Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. J Clin Oncol2014;32:15071515.

    • Search Google Scholar
    • Export Citation
  • 64.

    FourquetACampanaFZafraniB. Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. Int J Radiat Oncol Biol Phys1989;17:719725.

    • Search Google Scholar
    • Export Citation
  • 65.

    KomoikeYAkiyamaFIinoY. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases. Cancer2006;106:3541.

    • Search Google Scholar
    • Export Citation
  • 66.

    ZhouPGautamSRechtA. Factors affecting outcome for young women with early stage invasive breast cancer treated with breast-conserving therapy. Breast Cancer Res Treat2007;101:5157.

    • Search Google Scholar
    • Export Citation
  • 67.

    GolshanMMironANixonAJ. The prevalence of germline BRCA1 and BRCA2 mutations in young women with breast cancer undergoing breast-conservation therapy. Am J Surg2006;192:5862.

    • Search Google Scholar
    • Export Citation
  • 68.

    KromanNHoltvegHWohlfahrtJ. Effect of breast-conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma. Cancer2004;100:688693.

    • Search Google Scholar
    • Export Citation
  • 69.

    Blichert-ToftMNielsenMDuringM. Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol. Acta Oncol2008;47:672681.

    • Search Google Scholar
    • Export Citation
  • 70.

    LitiereSWerutskyGFentimanIS. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol2012;13:412419.

    • Search Google Scholar
    • Export Citation
  • 71.

    AgarwalSPappasLNeumayerL. Effect of breast conservation therapy vs mastectomy on disease-specific survival for early-stage breast cancer. JAMA Surg2014;149:267274.

    • Search Google Scholar
    • Export Citation
  • 72.

    HwangESLichtensztajnDYGomezSL. Survival after lumpectomy and mastectomy for early stage invasive breast cancer: the effect of age and hormone receptor status. Cancer2013;119:14021411.

    • Search Google Scholar
    • Export Citation
  • 73.

    Hartmann-JohnsenOJKaresenRSchlichtingENygardJF. Survival is better after breast conserving therapy than mastectomy for early stage breast cancer: a registry-based follow-up study of Norwegian women Primary operated between 1998 and 2008. Ann Surg Oncol2015;22:38363845.

    • Search Google Scholar
    • Export Citation
  • 74.

    ChatterjeeAPyferBCzernieckiB. Early postoperative outcomes in lumpectomy versus simple mastectomy. J Surg Res2015;198:143148.

  • 75.

    RechtA. Contralateral prophylactic mastectomy: caveat emptor. J Clin Oncol2009;27:13471349.

  • 76.

    BedrosianIHuCYChangGJ. Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients. J Natl Cancer Inst2010;102:401409.

    • Search Google Scholar
    • Export Citation
  • 77.

    JatoiIParsonsHM. Contralateral prophylactic mastectomy and its association with reduced mortality: evidence for selection bias. Breast Cancer Res Treat2014;148:389396.

    • Search Google Scholar
    • Export Citation
  • 78.

    PortschyPRKuntzKMTuttleTM. Survival outcomes after contralateral prophylactic mastectomy: a decision analysis. J Natl Cancer Inst2014;106.

    • Search Google Scholar
    • Export Citation
  • 79.

    FayanjuOMStollCRFowlerS. Contralateral prophylactic mastectomy after unilateral breast cancer: a systematic review and meta-analysis. Ann Surg2014;260:10001010.

    • Search Google Scholar
    • Export Citation
  • 80.

    RochaRDGirardiARPintoRRde FreitasVA. Axillary ultrasound and fine-needle aspiration in preoperative staging of axillary lymph nodes in patients with invasive breast cancer. Radiol Bras2015;48:345352.

    • Search Google Scholar
    • Export Citation
  • 81.

    BassSSLymanGHMcCannCR. Lymphatic mapping and sentinel lymph node biopsy. Breast J1999;5:288295.

  • 82.

    CoxCE. Lymphatic mapping in breast cancer: combination technique. Ann Surg Oncol2001;8:67S70S.

  • 83.

    CoxCENguyenKGrayRJ. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?Am Surg2001;67:513519.

  • 84.

    KragDWeaverDAshikagaT. The sentinel node in breast cancer--a multicenter validation study. N Engl J Med1998;339:941946.

  • 85.

    KragDNAndersonSJJulianTB. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol2010;11:927933.

    • Search Google Scholar
    • Export Citation
  • 86.

    KuehnTVoglFDHelmsG. Sentinel-node biopsy for axillary staging in breast cancer: results from a large prospective German multi-institutional trial. Eur J Surg Oncol2004;30:252259.

    • Search Google Scholar
    • Export Citation
  • 87.

    LymanGHGiulianoAESomerfieldMR. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol2005;23:77037720.

    • Search Google Scholar
    • Export Citation
  • 88.

    McMastersKMGiulianoAERossMI. Sentinel-lymph-node biopsy for breast cancer--not yet the standard of care. N Engl J Med1998;339:990995.

    • Search Google Scholar
    • Export Citation
  • 89.

    O'HeaBJHillADEl-ShirbinyAM. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg1998;186:423427.

    • Search Google Scholar
    • Export Citation
  • 90.

    VeronesiUPaganelliGVialeG. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med2003;349:546553.

    • Search Google Scholar
    • Export Citation
  • 91.

    ManselREFallowfieldLKissinM. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst2006;98:599609.

    • Search Google Scholar
    • Export Citation
  • 92.

    CoxCESaludCJCantorA. Learning curves for breast cancer sentinel lymph node mapping based on surgical volume analysis. J Am Coll Surg2001;193:593600.

    • Search Google Scholar
    • Export Citation
  • 93.

    DupontECoxCShiversS. Learning curves and breast cancer lymphatic mapping: institutional volume index. J Surg Res2001;97:9296.

  • 94.

    GiulianoAEHawesDBallmanKV. Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer. JAMA2011;306:385393.

    • Search Google Scholar
    • Export Citation
  • 95.

    DegnimACReynoldsCPantvaidyaG. Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am J Surg2005;190:543550.

    • Search Google Scholar
    • Export Citation
  • 96.

    HouvenaeghelGNosCGiardS. A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis. Eur J Surg Oncol2009;35:690695.

    • Search Google Scholar
    • Export Citation
  • 97.

    KatzASmithBLGolshanM. Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer. J Clin Oncol2008;26:20932098.

    • Search Google Scholar
    • Export Citation
  • 98.

    KohrtHEOlshenRABermasHR. New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BMC Cancer2008;8:66.

    • Search Google Scholar
    • Export Citation
  • 99.

    ScowJSDegnimACHoskinTL. Assessment of the performance of the Stanford Online Calculator for the prediction of nonsentinel lymph node metastasis in sentinel lymph node-positive breast cancer patients. Cancer2009;115:40644070.

    • Search Google Scholar
    • Export Citation
  • 100.

    van la ParraRFErnstMFBevilacquaJL. Validation of a nomogram to predict the risk of nonsentinel lymph node metastases in breast cancer patients with a positive sentinel node biopsy: validation of the MSKCC breast nomogram. Ann Surg Oncol2009;16:11281135.

    • Search Google Scholar
    • Export Citation
  • 101.

    WerkoffGLambaudieEFondrinierE. Prospective multicenter comparison of models to predict four or more involved axillary lymph nodes in patients with breast cancer with one to three metastatic sentinel lymph nodes. J Clin Oncol2009;27:57075712.

    • Search Google Scholar
    • Export Citation
  • 102.

    GiulianoAEMcCallLBeitschP. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg2010;252:426432; discussion 432–423.

    • Search Google Scholar
    • Export Citation
  • 103.

    GiulianoAEHuntKKBallmanKV. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA2011;305:569575.

    • Search Google Scholar
    • Export Citation
  • 104.

    AxelssonCKMouridsenHTZedelerK. Axillary dissection of level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG). Eur J Cancer1992;28A:14151418.

    • Search Google Scholar
    • Export Citation
  • 105.

    KiricutaCITauschJ. A mathematical model of axillary lymph node involvement based on 1446 complete axillary dissections in patients with breast carcinoma. Cancer1992;69:24962501.

    • Search Google Scholar
    • Export Citation
  • 106.

    FisherBRedmondCFisherER. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med1985;312:674681.

    • Search Google Scholar
    • Export Citation
  • 107.

    AntoniniNJonesHHoriotJC. Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882. Radiother Oncol2007;82:265271.

    • Search Google Scholar
    • Export Citation
  • 108.

    BartelinkHHoriotJCPoortmansP. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med2001;345:13781387.

    • Search Google Scholar
    • Export Citation
  • 109.

    PignolJPOlivottoIRakovitchE. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol2008;26:20852092.

    • Search Google Scholar
    • Export Citation
  • 110.

    MukeshMBBarnettGCWilkinsonJS. Randomized controlled trial of intensity-modulated radiotherapy for early breast cancer: 5-year results confirm superior overall cosmesis. J Clin Oncol2013;31:44884495.

    • Search Google Scholar
    • Export Citation
  • 111.

    MulliezTVeldemanLvan GrevelingA. Hypofractionated whole breast irradiation for patients with large breasts: a randomized trial comparing prone and supine positions. Radiother Oncol2013;108:203208.

    • Search Google Scholar
    • Export Citation
  • 112.

    START Trialists' GroupBentzenSMAgrawalRK. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet2008;371:10981107.

    • Search Google Scholar
    • Export Citation
  • 113.

    START Trialists' GroupBentzenSMAgrawalRK. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol2008;9:331341.

    • Search Google Scholar
    • Export Citation
  • 114.

    OwenJRAshtonABlissJM. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol2006;7:467471.

    • Search Google Scholar
    • Export Citation
  • 115.

    WhelanTJPignolJPLevineMN. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med2010;362:513520.

  • 116.

    HavilandJSOwenJRDewarJA. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol2013;14:10861094.

    • Search Google Scholar
    • Export Citation
  • 117.

    BartelinkHHoriotJCPoortmansPM. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol2007;25:32593265.

    • Search Google Scholar
    • Export Citation
  • 118.

    RomestaingPLehingueYCarrieC. Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. J Clin Oncol1997;15:963968.

    • Search Google Scholar
    • Export Citation
  • 119.

    VrielingCColletteLFourquetA. The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC ‘boost vs. no boost’ trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. Radiother Oncol2000;55:219232.

    • Search Google Scholar
    • Export Citation
  • 120.

    JonesHAAntoniniNHartAA. Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial. J Clin Oncol2009;27:49394947.

    • Search Google Scholar
    • Export Citation
  • 121.

    WhelanTJOlivottoIAParulekarWR. Regional nodal irradiation in early-stage breast cancer. N Engl J Med2015;373:307316.

  • 122.

    PoortmansPMColletteSKirkoveC. Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med2015;373:317327.

    • Search Google Scholar
    • Export Citation
  • 123.

    McCormickB. Partial-breast radiation for early staged breast cancers: hypothesis, existing data, and a planned phase III trial. J Natl Compr Canc Netw2005;3:301307.

    • Search Google Scholar
    • Export Citation
  • 124.

    SmithBDArthurDWBuchholzTA. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys2009;74:9871001.

    • Search Google Scholar
    • Export Citation
  • 125.

    ShaitelmanSFViciniFABeitschP. Five-year outcome of patients classified using the American Society for Radiation Oncology consensus statement guidelines for the application of accelerated partial breast irradiation: an analysis of patients treated on the American Society of Breast Surgeons MammoSite Registry Trial. Cancer2010;116:46774685.

    • Search Google Scholar
    • Export Citation
  • 126.

    ViciniFArthurDWazerD. Limitations of the American Society of Therapeutic Radiology and Oncology Consensus Panel Guidelines on the use of accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys2011;79:977984.

    • Search Google Scholar
    • Export Citation
  • 127.

    BellonJRComeSEGelmanRS. Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial. J Clin Oncol2005;23:19341940.

    • Search Google Scholar
    • Export Citation
  • 128.

    RechtAComeSEHendersonIC. The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N Engl J Med1996;334:13561361.

    • Search Google Scholar
    • Export Citation
  • 129.

    HughesKSSchnaperLABerryD. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med2004;351:971977.

    • Search Google Scholar
    • Export Citation
  • 130.

    HughesKSSchnaperLABellonJR. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol2013;31:23822387.

    • Search Google Scholar
    • Export Citation
  • 131.

    FylesAWMcCreadyDRManchulLA. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med2004;351:963970.

    • Search Google Scholar
    • Export Citation
  • 132.

    KunklerIHWilliamsLJJackWJ. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial. Lancet Oncol2015;16:266273.

    • Search Google Scholar
    • Export Citation
  • 133.

    HellmanS. Stopping metastases at their source. N Engl J Med1997;337:996997.

  • 134.

    OvergaardMHansenPSOvergaardJ. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med1997;337:949955.

    • Search Google Scholar
    • Export Citation
  • 135.

    OvergaardMJensenMBOvergaardJ. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet1999;353:16411648.

    • Search Google Scholar
    • Export Citation
  • 136.

    RagazJOlivottoIASpinelliJJ. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst2005;97:116126.

    • Search Google Scholar
    • Export Citation
  • 137.

    RechtAEdgeSBSolinLJ. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol2001;19:15391569.

    • Search Google Scholar
    • Export Citation
  • 138.

    Early Breast Cancer Trialists' Collaborative GroupMcGalePTaylorC. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet2014;383:21272135.

    • Search Google Scholar
    • Export Citation
  • 139.

    HuangEHTuckerSLStromEA. Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy. J Clin Oncol2004;22:46914699.

    • Search Google Scholar
    • Export Citation
  • 140.

    McGuireSEGonzalez-AnguloAMHuangEH. Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy. Int J Radiat Oncol Biol Phys2007;68:10041009.

    • Search Google Scholar
    • Export Citation
  • 141.

    OvergaardMNielsenHMOvergaardJ. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. Radiother Oncol2007;82:247253.

    • Search Google Scholar
    • Export Citation
  • 142.

    NielsenHMOvergaardMGrauC. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies. J Clin Oncol2006;24:22682275.

    • Search Google Scholar
    • Export Citation
  • 143.

    JagsiRRaadRAGoldbergS. Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation. Int J Radiat Oncol Biol Phys2005;62:10351039.

    • Search Google Scholar
    • Export Citation
  • 144.

    AbdulkarimBSCuarteroJHansonJ. Increased risk of locoregional recurrence for women With T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy. J Clin Oncol2011;29:28522858.

    • Search Google Scholar
    • Export Citation
  • 145.

    McLaughlinJMAndersonRTFerketichAK. Effect on survival of longer intervals between confirmed diagnosis and treatment initiation among low-income women with breast cancer. J Clin Oncol2012;30:44934500.

    • Search Google Scholar
    • Export Citation
  • 146.

    LiuASKaoHKReishRG. Postoperative complications in prosthesis-based breast reconstruction using acellular dermal matrix. Plast Reconstr Surg2011;127:17551762.

    • Search Google Scholar
    • Export Citation
  • 147.

    McCarthyCMMehraraBJRiedelE. Predicting complications following expander/implant breast reconstruction: an outcomes analysis based on preoperative clinical risk. Plast Reconstr Surg2008;121:18861892.

    • Search Google Scholar
    • Export Citation
  • 148.

    CowenDGrossERouannetP. Immediate post-mastectomy breast reconstruction followed by radiotherapy: risk factors for complications. Breast Cancer Res Treat2010;121:627634.

    • Search Google Scholar
    • Export Citation
  • 149.

    WoerdemanLAHageJJHoflandMMRutgersEJ. A prospective assessment of surgical risk factors in 400 cases of skin-sparing mastectomy and immediate breast reconstruction with implants to establish selection criteria. Plast Reconstr Surg2007;119:455463.

    • Search Google Scholar
    • Export Citation
  • 150.

    AntonyAKMcCarthyCMCordeiroPG. Acellular human dermis implantation in 153 immediate two-stage tissue expander breast reconstructions: determining the incidence and significant predictors of complications. Plast Reconstr Surg2010;125:16061614.

    • Search Google Scholar
    • Export Citation
  • 151.

    AhmedSSnellingABainsMWhitworthIH. Breast reconstruction. BMJ2005;330:943948.

  • 152.

    EdlichRFWintersKLFaulknerBC. Advances in breast reconstruction after mastectomy. J Long Term Eff Med Implants2005;15:197207.

  • 153.

    PenningtonDG. Breast reconstruction after mastectomy: current state of the art. ANZ J Surg2005;75:454458.

  • 154.

    ChangDW. Breast reconstruction with microvascular MS-TRAM and DIEP flaps. Arch Plast Surg2012;39:310.

  • 155.

    KronowitzSJRobbGL. Radiation therapy and breast reconstruction: a critical review of the literature. Plast Reconstr Surg2009;124:395408.

    • Search Google Scholar
    • Export Citation
  • 156.

    TranNVChangDWGuptaA. Comparison of immediate and delayed free TRAM flap breast reconstruction in patients receiving postmastectomy radiation therapy. Plast Reconstr Surg2001;108:7882.

    • Search Google Scholar
    • Export Citation
  • 157.

    MehtaVKGoffinetD. Postmastectomy radiation therapy after TRAM flap breast reconstruction. Breast J2004;10:118122.

  • 158.

    BerryTBrooksSSydowN. Complication rates of radiation on tissue expander and autologous tissue breast reconstruction. Ann Surg Oncol2010;17(Suppl 3):202210.

    • Search Google Scholar
    • Export Citation
  • 159.

    FrancisSHRubergRLStevensonKB. Independent risk factors for infection in tissue expander breast reconstruction. Plast Reconstr Surg2009;124:17901796.

    • Search Google Scholar
    • Export Citation
  • 160.

    ColwellASDamjanovicBZahediB. Retrospective review of 331 consecutive immediate single-stage implant reconstructions with acellular dermal matrix: indications, complications, trends, and costs. Plast Reconstr Surg2011;128:11701178.

    • Search Google Scholar
    • Export Citation
  • 161.

    Garcia-EtienneCACody IiiHSDisaJJ. Nipple-sparing mastectomy: initial experience at the Memorial Sloan-Kettering Cancer Center and a comprehensive review of literature. Breast J2009;15:440449.

    • Search Google Scholar
    • Export Citation
  • 162.

    PetitJYVeronesiUOrecchiaR. Nipple sparing mastectomy with nipple areola intraoperative radiotherapy: one thousand and one cases of a five years experience at the European Institute of Oncology of Milan (EIO). Breast Cancer Res Treat2009;117:333338.

    • Search Google Scholar
    • Export Citation
  • 163.

    YuehJHHoulihanMJSlavinSA. Nipple-sparing mastectomy: evaluation of patient satisfaction, aesthetic results, and sensation. Ann Plast Surg2009;62:586590.

    • Search Google Scholar
    • Export Citation
  • 164.

    ChungAPSacchiniV. Nipple-sparing mastectomy: where are we now?Surg Oncol2008;17:261266.

  • 165.

    GerberBKrauseADieterichM. The oncological safety of skin sparing mastectomy with conservation of the nipple-areola complex and autologous reconstruction: an extended follow-up study. Ann Surg2009;249:461468.

    • Search Google Scholar
    • Export Citation
  • 166.

    MallonPFeronJGCouturaudB. The role of nipple-sparing mastectomy in breast cancer: a comprehensive review of the literature. Plast Reconstr Surg2013;131:969984.

    • Search Google Scholar
    • Export Citation
  • 167.

    PiperMPeledAWFosterRD. Total skin-sparing mastectomy: a systematic review of oncologic outcomes and postoperative complications. Ann Plast Surg2013;70:435437.

    • Search Google Scholar
    • Export Citation
  • 168.

    TothBAForleyBGCalabriaR. Retrospective study of the skin-sparing mastectomy in breast reconstruction. Plast Reconstr Surg1999;104:7784.

    • Search Google Scholar
    • Export Citation
  • 169.

    CarlsonGWStybloTMLylesRH. The use of skin sparing mastectomy in the treatment of breast cancer: the Emory experience. Surg Oncol2003;12:265269.

    • Search Google Scholar
    • Export Citation
  • 170.

    DownesKJGlattBSKanchwalaSK. Skin-sparing mastectomy and immediate reconstruction is an acceptable treatment option for patients with high-risk breast carcinoma. Cancer2005;103:906913.

    • Search Google Scholar
    • Export Citation
  • 171.

    FosterRDEssermanLJAnthonyJP. Skin-sparing mastectomy and immediate breast reconstruction: a prospective cohort study for the treatment of advanced stages of breast carcinoma. Ann Surg Oncol2002;9:462466.

    • Search Google Scholar
    • Export Citation
  • 172.

    Medina-FrancoHVasconezLOFixRJ. Factors associated with local recurrence after skin-sparing mastectomy and immediate breast reconstruction for invasive breast cancer. Ann Surg2002;235:814819.

    • Search Google Scholar
    • Export Citation
  • 173.

    NewmanLAKuererHMHuntKK. Presentation, treatment, and outcome of local recurrence after skin-sparing mastectomy and immediate breast reconstruction. Ann Surg Oncol1998;5:620626.

    • Search Google Scholar
    • Export Citation
  • 174.

    CloughKBKaufmanGJNosC. Improving breast cancer surgery: a classification and quadrant per quadrant atlas for oncoplastic surgery. Ann Surg Oncol2010;17:13751391.

    • Search Google Scholar
    • Export Citation
  • 175.

    AndersonBOMasettiRSilversteinMJ. Oncoplastic approaches to partial mastectomy: an overview of volume-displacement techniques. Lancet Oncol2005;6:145157.

    • Search Google Scholar
    • Export Citation
  • 176.

    HuemerGMSchrenkPMoserF. Oncoplastic techniques allow breast-conserving treatment in centrally located breast cancers. Plast Reconstr Surg2007;120:390398.

    • Search Google Scholar
    • Export Citation
  • 177.

    KaurNPetitJYRietjensM. Comparative study of surgical margins in oncoplastic surgery and quadrantectomy in breast cancer. Ann Surg Oncol2005;12:539545.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 1525 1525 132
PDF Downloads 413 413 39
EPUB Downloads 0 0 0